Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
09/30/1999 | WO1999048506A2 Composition containing at least one metal yeast for pharmaceutical use and/or for use as a nutrition supplement, for humans or animals |
09/30/1999 | WO1999048505A1 Pharmacological composition based on minerals |
09/30/1999 | WO1999048482A2 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
09/30/1999 | WO1999040945A3 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
09/30/1999 | WO1999038518A3 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation |
09/30/1999 | WO1999036562A9 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
09/30/1999 | WO1999035277A3 Recombinant, active caspases and uses thereof |
09/30/1999 | WO1999035245A9 Methods for preparing and using immortalized human neuroendocrine cells |
09/30/1999 | WO1999035242A9 Media for neuroendocrine cells |
09/30/1999 | WO1999031261A9 SELECTIVE KILLING AND DIAGNOSIS OF p53+ NEOPLASTIC CELLS |
09/30/1999 | CA2325634A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
09/30/1999 | CA2324350A1 Cardiac-derived stem cells |
09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
09/30/1999 | CA2323501A1 Compounds related to pap-1 |
09/30/1999 | CA2233725A1 Hemoglobin-hydroxyethyl starch complexes |
09/29/1999 | EP0945138A1 Transfection particles |
09/29/1999 | EP0944724A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE $g(b) AS MEDICINE |
09/29/1999 | EP0944717A1 Method for producing recombinant adenovirus |
09/29/1999 | EP0944647A1 Submucosa extracts |
09/29/1999 | EP0775007B1 Enhanced yield blood processing device with angled interface control surface |
09/29/1999 | EP0474645B1 Protein complex |
09/29/1999 | CN1230220A Therapy for 'alpha'-galactosidase deficiency |
09/29/1999 | CN1229671A Medicament 'Yujingling' for treating sexual disorder and its prepn. method |
09/29/1999 | CN1229669A Extract for treating sore and carbuncle |
09/29/1999 | CN1229667A Pill for relief of choke |
09/29/1999 | CN1229666A Chilblain paste |
09/29/1999 | CN1229663A Chinese medicinal prescription for treating liver cancer |
09/29/1999 | CN1229657A Haisong injury paste |
09/29/1999 | CN1229655A Medicinal decoction for treating diabets mellitus |
09/29/1999 | CN1229652A Compound fish oil |
09/29/1999 | CN1045254C Chilblain paste |
09/28/1999 | US5958902 Method and composition for treating sleep apnea |
09/28/1999 | US5958887 Use of a hymenoptera venom for the manufacture of a medicament for treating DNA virus infections |
09/28/1999 | US5958767 Engraftable human neural stem cells |
09/28/1999 | US5958732 Anticoagulants in snake venom |
09/28/1999 | US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder |
09/28/1999 | US5958709 Processes for identifying compounds that bind to the human Y4 receptor |
09/28/1999 | US5958682 Virus-directed enzyme prodrug therapy for treating tumor cells consisting of a viral vector encoding bacterial nitroreductase capable of converting a prodrug into a cytotoxic drug operably linked to a promoter; and the prodrug |
09/28/1999 | US5958670 Method of freezing cells and cell-like materials |
09/28/1999 | US5958425 Viral vaccines |
09/28/1999 | US5958404 Grafting cells for treatment of disease and diabetes |
09/28/1999 | US5958253 Centrifuge reagent delivery method |
09/28/1999 | US5958250 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
09/28/1999 | CA2187803C Methods of treating disease using sertoli cells and allografts or xenografts |
09/27/1999 | CA2266805A1 Cell-based gene therapy in the treatment of pulmonary disorders |
09/27/1999 | CA2227425A1 Cell-based gene therapy |
09/26/1999 | CA2264260A1 Polynucleotide molecules encoding neospora proteins |
09/24/1999 | CA2249660A1 Novel compounds |
09/23/1999 | WO1999047687A1 Enhanced anti-tumor immunity |
09/23/1999 | WO1999047674A2 Compounds and methods for therapy and diagnosis of lung cancer |
09/23/1999 | WO1999047660A1 Retroviral packaging cell line |
09/23/1999 | WO1999047653A1 Suicide gene therapy system for the treatment of brain tumours |
09/23/1999 | WO1999047642A2 Development of normal offspring from oocytes injected with freeze-dried spermatozoa |
09/23/1999 | WO1999047641A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
09/23/1999 | WO1999047227A1 Removal of contaminants from biological products |
09/23/1999 | WO1999047178A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
09/23/1999 | WO1999047169A1 Methods to provoke anti-cancer immune responses |
09/23/1999 | WO1999047163A2 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
09/23/1999 | WO1999047129A1 Crosslinkable macromers bearing initiator groups |
09/23/1999 | WO1999047102A2 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby |
09/23/1999 | WO1999046992A1 Induction of immunity against tumor self-antigens |
09/23/1999 | WO1999046988A1 Compositions and methods for antigen-specific vaccination |
09/23/1999 | WO1999046984A1 Compositions and methods for the frozen storage of dendritic cells |
09/23/1999 | WO1999046982A1 Porcine nuclear transfer |
09/23/1999 | WO1999041369A3 Genetic vaccine vector engineering |
09/23/1999 | WO1999038955A3 Mutant herpes simplex viruses and uses thereof |
09/23/1999 | CA2324138A1 Novel complementing receptor-ligand pairs and adoptive immunotherapy using same |
09/23/1999 | CA2324009A1 Porcine nuclear transfer |
09/23/1999 | CA2323897A1 Suicide gene therapy system for the treatment of brain tumours |
09/23/1999 | CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer |
09/23/1999 | CA2322660A1 Enhanced anti-tumor immunity |
09/23/1999 | CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
09/23/1999 | CA2322623A1 Development of normal offspring from oocytes injected with freeze-dried spermatozoa |
09/22/1999 | EP0943680A1 Suicide gene therapy system for the treatment of brain tumours |
09/22/1999 | EP0943334A1 Tortoise oil, turtle oil, compositions containing them, their preparation processes and uses |
09/22/1999 | EP0942961A1 Process for producing tumoricide t-lymphocytes |
09/22/1999 | EP0942755A2 Treatment of diabetes with transcription factor gene |
09/22/1999 | EP0942742A1 Therapeutic compositions for treatment of cancer |
09/22/1999 | EP0942739A1 Biomaterial derived from vertebrate liver tissue |
09/22/1999 | EP0771324B1 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
09/22/1999 | EP0449948B1 Grafting genetically modified cells to treat diseases of the central nervous system |
09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
09/22/1999 | CN1228994A Pharmaceutical composition of hedgehog proteins and use thereof |
09/22/1999 | CN1228990A Prescription of antasthmatic powder and preparation method thereof |
09/22/1999 | CN1228989A Food produced from wood frog oil and making method |
09/22/1999 | CN1228988A 10 drops- for treating stomach disease |
09/22/1999 | CN1228986A Burn ointment |
09/22/1999 | CN1228983A Mongolian medicine prescription for treating skin disease and preparation method thereof |
09/22/1999 | CN1228982A Medicine for treating gynaecologic pelvic tumour and preparation method thereof |
09/22/1999 | CN1228971A Health-care mattress with functions dispelling wind and clearing away cold, removing dampness and warming kidney |
09/22/1999 | CN1228969A A set of medicine for prevention and curing of cholesthiasis disease and plan for discriminating choleithiasis kind |
09/22/1999 | CN1228965A Medicin containing selenium element |
09/22/1999 | CN1228964A Preparation method of calcium enriched preparation using birds eggshell as raw material |
09/22/1999 | CN1228963A Medicine for treating senile dementia, paralysis agitants and cardio-cerebral angiopathy |
09/22/1999 | CN1228942A Aquatic product containing low heavy water rate |
09/22/1999 | CN1228929A Technology for broken wall of melissa pollen |
09/22/1999 | CN1045165C Bueaty agent and production method thereof |
09/22/1999 | CN1045163C Method for extracting phospholipid from human embryo brain used in cosmetics |
09/21/1999 | US5955441 Genetic inhibition of complement mediated inflammatory response |
09/21/1999 | US5955357 In-vitro-derived human neutrophil precursor cells |